Reading EMR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track EMR free→Reading EMR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track EMR free→NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, while earnings quality and management's recent track record are neutral. The sector backdrop is a headwind, and risk is moderate. Peer multiples imply a price about 17% above where it trades (it looks cheap on this basis); the read is fair. Key factors to watch include guidance changes and sector trends, as these could significantly impact EMR's performance. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 8 valuation methods, at three horizons. Current price $143.07. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $143 EMR trades at 27× p/e, below its 32× p/e peer median. Our $172 fair value sits above the price; high confidence. Analysts: $144–$175. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 17% below a flat-multiple fair value, below our forecast of about 6%. This describes what's priced in, not a forecast of the move.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated strong grew net income 69% of the time over the next year (vs 58% for the rest of the cohort, n=3696).
Over the trailing year it converted 1.45x of net income into operating cash flow. Historically, Industrials names rated neutral grew net income 57% of the time over the next year (vs 60% for the rest of the cohort, n=4440).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.68 → $1.68 (-0.1% / 30d). 9 raised, 5 cut, 21 covering analysts.
0 upgrades, 0 downgrades / 30d. 62% of analysts rate Buy.
1 PT revisions / 30d. Avg target 22.9% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$142.
How much price usually moves either way.
On a bad day, this stock has moved -$334.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,346.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Weak sales growth could signal ongoing challenges in the industrial sector. This impacts investor confidence.
Confirms:Q3 net sales growth guidance of 4.5% or lower.
Disproves:Q3 net sales growth guidance above 4.5%.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for EMR yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition Quarterly Results Press Release On Tuesday, May 5, 2026, a press release was issued regarding the second quarter results of Emerson Electric Co. (the “Company”). A copy of this press release is furnished with this Current Report on Form 8-K as Exhibit 99.1. References to underlying orders in the press release refer to the Company's trailing three-month average orders growth versus the prior year, excluding currency, and significant acquisitions an…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$144.00 – $175.00 (median $159.50) · 4 analysts · as of 2026-06-09
Looks cheaper than most peers in the same business.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Electrical Components & Equipment.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
EMR Emerson Electric | Typical Show detailsSector percentile: 61 of 100 | fair | moderate |
ETN Eaton Corporation | Above typical Show detailsSector percentile: 77 of 100 | full | moderate |
VRT Vertiv | Typical Show detailsSector percentile: 58 of 100 | expensive | elevated |
BE Bloom Energy Corp. | Typical Show detailsSector percentile: 41 of 100 | expensive | high |
AME Ametek | Above typical Show detailsSector percentile: 91 of 100 | fair | low |
6 material management or governance events in the past 24 months, led by executive changes. Historically, Industrials names rated neutral grew net income 59% of the time over the next year (vs 60% for the rest of the cohort, n=1113).
Not investment advice. As of 2026-06-12.
via XLI
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Met or beat guidance 88% of the last 8 guided quarters · 51.5% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Emerson plans to return approximately $2.2 billion to shareholders through share repurchases and dividends in 2026.
Emerson aims to achieve free cash flow between $3.5 billion and $3.6 billion for fiscal year 2026.
Emerson aims to maintain its EPS guidance range of $4.79 to $4.89 for fiscal year 2026.
Why it matters: Returning $2.2B to shareholders is crucial. Slow progress may worry investors.
Confirms:Progress report shows less than $1B returned to shareholders by mid-2026.
Disproves:Progress report shows over $1B returned to shareholders by mid-2026.
Why it matters: Keeping EPS guidance shows trust in steady earnings. This can help stock performance.
Confirms:EPS guidance remains within the range of $4.79 to $4.89.
Disproves:EPS guidance revised down below $4.79.
Why it matters: Falling free cash flow could limit capital return plans and raise concerns about financial health.
Confirms:Free cash flow reported below $3.5B.
Disproves:Free cash flow reported at or above $3.5B.
Why it matters: Slower order growth may mean less demand. This can affect future revenue.
Confirms:Orders growth was below 5%.
Disproves:Underlying orders growth reported at or above 5%.
Why it matters: If sector growth speeds up, it could benefit Emerson's sales. Slower growth may hurt.
Confirms one read:Sector revenue growth speeds up to over 10% each year.
Confirms the other:Sector revenue growth slows below 5% year over year.
Director — Jennifer G. Newstead: Election of a new director with significant experience.
Entry Into a Material Definitive Agreement. The information provided in
Results of Operations and Financial Condition Quarterly Results Press Release On Tuesday, February 3, 2026, a press release was issued regarding the first quarter results of Emerson Electric Co. (the “Company”). A copy of this press release is furnished with this Current Report on Form 8-K as Exhibit 99.1. References to underlying orders in the press release refer to the Company's trailing three-month average orders growth versus the prior year, excluding currency, and significant acquisition…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On February 10, 2026, Emerson Electric Co. (the "Company") entered into a $2 billion 364-Day Credit Agreement (the “364-Day Credit Facility”), dated as of February 10, 2026, with JPMorgan Chase Bank, N.A., as agent, Bank of America, N.A., Citibank, N.A., and Goldman Sachs Bank USA, as syndication agents, and the lenders named therein. The 364-Day Credit Facility expires on Februa…